Name	Value
Compound	Ly5
Investigated event	Influence on protein activity in presence of OSM
Experiment type	Western Blot
Concentration	1.00 µM
Cell line	SJSA
Organism	Homo sapiens
Animal model
STAT protein
Other	GAPDH

Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. PloS one Peter Y Yu, Heather L Gardner, Ryan Roberts, Hakan Cam, Seethalakshmi Hariharan, Ling Ren, Amy K LeBlanc, Hui Xiao, Jiayuh Lin, Denis C Guttridge, Xiaokui Mo, Chad E Bennett, Christopher C Coss, Yonghua Ling, Mitch A Phelps, Peter Houghton, Cheryl A London, 12, 7, None, 2017-07-27, 10.1371/journal.pone.0181885 DOI: 10.1371/journal.pone.0181885 PUBMED: 28750090 PMCID: PMC5531494